Literature DB >> 4796

Simple model for hormone-activated adenylate cyclase systems.

G G Hammes, M Rodbell.   

Abstract

A simple model is developed to explain the activation of rat liver plasma membrane adenylate cyclase [ATP pyrophosphate-lyase (cyclizing), EC 4.6.1.1] by guanosine nucleotides and glucagon and the dependence of the cATALYTIC RATE ON Mg2+, H+, and substrate concentrations. The basic model proposes that the adenylate cyclase system can exist in two states, A and B; that activating ligands bind preferentially to the B state; and that only the B state is active. Kinetic data are quantitatively fit to this model, and the binding constants for the interaction of the A and B states with glucagon, GTP, and guanyl-5'-ylimidodiphosphate are obtinaed. The substrates ATP and adenyl-5'-ylimidodiphosphate appear to show little preference between the A and B states, and simple Michaelis-Menten kinetics are sufficient to describe the dependence of the catalytic rate on substrate concentration under optimal conditions. The dependence of the rate on pH can be explained by postulating that one ionizable group in its acid form and one ionizable group in its basic form must be present at the active site in order for catalysis to occur. The activation and inhibition of the activity by Mg2+ can be explained by a similar mechanism with Mg2+ binding to activating and inhibiting sites. Glucagon and guanosine nucleotides appear to influence the dependence of the rate on Mg2+ and glucagon. The Mg2+ also may display some preference for the B state. A comparison of this model with others that have been proposed is given. The proposed model appears to provide a simple conceptual frame-work that is applicable to many adenylate cyclase systems.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 4796      PMCID: PMC430226          DOI: 10.1073/pnas.73.4.1189

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  15 in total

1.  The control of adenylate cyclase by calcium in turkey erythrocyte ghosts.

Authors:  M L Steer; A Levitzki
Journal:  J Biol Chem       Date:  1975-03-25       Impact factor: 5.157

2.  ON THE NATURE OF ALLOSTERIC TRANSITIONS: A PLAUSIBLE MODEL.

Authors:  J MONOD; J WYMAN; J P CHANGEUX
Journal:  J Mol Biol       Date:  1965-05       Impact factor: 5.469

3.  Multiple inhibitory and activating effects of nucleotides and magnesium on adrenal adenylate cyclase.

Authors:  C Londos; M Rodbell
Journal:  J Biol Chem       Date:  1975-05-10       Impact factor: 5.157

4.  The hepatic adenylate cyclase system. II. Substrate binding and utilization and the effects of magnesium ion and pH.

Authors:  M C Lin; Y Salomon; M Rendell; M Rodbell
Journal:  J Biol Chem       Date:  1975-06-10       Impact factor: 5.157

5.  On the mechanism of activation of fat cell adenylate cyclase by guanine nucleotides. An explanation for the biphasic inhibitory and stimulatory effects of the nucleotides and the role of hormones.

Authors:  M Rodbell
Journal:  J Biol Chem       Date:  1975-08-10       Impact factor: 5.157

6.  Adenyl cyclase in fat cells. 1. Properties and the effects of adrenocorticotropin and fluoride.

Authors:  L Birnbaumer; S L Pohl; M Rodbell
Journal:  J Biol Chem       Date:  1969-07-10       Impact factor: 5.157

Review 7.  Cyclic AMP.

Authors:  G A Robison; R W Butcher; E W Sutherland
Journal:  Annu Rev Biochem       Date:  1968       Impact factor: 23.643

8.  Metal and metal-ATP interactions with brain and cardiac adenylate cyclases.

Authors:  D L Garbers; R A Johnson
Journal:  J Biol Chem       Date:  1975-11-10       Impact factor: 5.157

9.  The hepatic adenylate cyclase system. III. A mathematical model for the steady state kinetics of catalysis and nucleotide regulation.

Authors:  M Rendell; Y Salomon; M C Lin; M Rodbell; M Berman
Journal:  J Biol Chem       Date:  1975-06-10       Impact factor: 5.157

10.  The hepatic adenylate cyclase system. I. Evidence for transition states and structural requirements for guanine nucloetide activiation.

Authors:  Y Salomon; M C Lin; C Londos; M Rendell; M Rodbell
Journal:  J Biol Chem       Date:  1975-06-10       Impact factor: 5.157

View more
  8 in total

1.  Adrenal cortex adenylate cyclase. In vitro modification of the enzyme by cholera toxin.

Authors:  H Glossmann; C J Struck
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-09       Impact factor: 3.000

2.  Modulation of the response of bovine adrenocortical adenylate cyclase to corticotropin.

Authors:  P Glynn; D M Cooper; D Schulster
Journal:  Biochem J       Date:  1977-11-15       Impact factor: 3.857

Review 3.  Adenylate cyclase: the role of magnesium and other divalent cations.

Authors:  S Y Cech; W C Broaddus; M E Maguire
Journal:  Mol Cell Biochem       Date:  1980-12-10       Impact factor: 3.396

4.  Localization of adenylate cyclase activity in the tissues of an intact planarian Dugesia lugubris (O. Schmidt).

Authors:  J Moraczewski; A Duma
Journal:  Histochemistry       Date:  1981

5.  Secretin and VIP-stimulated adenylate cyclase from rat heart. I. General properties and structural requirements for enzyme activation.

Authors:  P Chatelain; P Robberecht; P De Neef; M Deschodt-Lanckman; W König; J Christophe
Journal:  Pflugers Arch       Date:  1980-12       Impact factor: 3.657

6.  A model for the regulation of brain adenylate cyclase by ionic equilibria.

Authors:  H Ohanian; K Borhanian; S de Farias; A Bennun
Journal:  J Bioenerg Biomembr       Date:  1981-12       Impact factor: 2.945

7.  Stabilization and solubilization of bovine corpus-luteum adenylate cyclase. The effects of guanosine triphosphate, guanosine 5'-[beta,gamma-imido]triphosphate, sodium fluoride and Tris/hydrochloric acid concentration on enzyme activity.

Authors:  J L Young; D A Stansfield
Journal:  Biochem J       Date:  1978-01-01       Impact factor: 3.857

8.  Activation of cardiac adenylate cyclase: horminal modification of the magnesium ion requirement.

Authors:  R Alvarez; J J Bruno
Journal:  Proc Natl Acad Sci U S A       Date:  1977-01       Impact factor: 11.205

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.